Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
Barzon
L
L
Fallo
F
F
Sonino
N
N
Daniele
O
O
Boscaro
M
M
D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008297:Male; D008939:Mitotane / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane